House of Representatives refers ASAP Act to committees
November 19, 2025
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Currently in_committee. The next step in the legislative lifecycle is Floor Vote.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
The bill is in the initial referral stage, meaning its specific impact on energy policy, tax law, or commerce regulations remains to be defined by the committees of .
Potentially affected actors named in the source documents. Mention is not a position.
Committee on Energy and Commerce
The committee is tasked with reviewing the bill's provisions related to energy and commerce.
Committee on Ways and Means
The committee is tasked with reviewing the bill's provisions related to tax and revenue jurisdiction.
Current stage: in_committee.
Floor Vote.
Summary
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Why It Matters
The bill is in the initial referral stage, meaning its specific impact on energy policy, tax law, or commerce regulations remains to be defined by the committees of .
Frequently Asked Questions
What does the ASAP Act do?
Which committees are reviewing this bill?
News Coverage
Lobbying Activity
ACADIA PHARMACEUTICALS
2026
“Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.”
Sponsors
Connected Entities
Analysis Score
0–100- Significance20How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools